Invention Grant
- Patent Title: Nitrogenated derivatives of pancratistatin
- Patent Title (中): pancratistatin的氮化衍生物
-
Application No.: US13727101Application Date: 2012-12-26
-
Publication No.: US08697064B2Publication Date: 2014-04-15
- Inventor: Frédéric Marion , Jean-Philippe Annereau , Jacques Fahy
- Applicant: Pierre Fabre Medicament
- Applicant Address: FR Boulogne-Billancourt
- Assignee: Pierre Fabre Medicament
- Current Assignee: Pierre Fabre Medicament
- Current Assignee Address: FR Boulogne-Billancourt
- Agency: Birch, Stewart, Kolasch & Birch, LLP
- Priority: FR0855161 20080728
- Main IPC: C07D491/04
- IPC: C07D491/04 ; A61K31/4741 ; A61K31/513 ; A61K31/52 ; A61K31/5377 ; A61K31/664 ; A61K31/704 ; A61K31/7056
Abstract:
The present invention concerns nitrogenated derivatives of narciclasine and pancratistatin of the following general formula (I) as well as their pharmaceutically acceptable salts. The present invention also concerns the use of these compounds in cancer therapy as well as a method for their preparation.
Public/Granted literature
- US20130121986A1 NITROGENATED DERIVATIVES OF PANCRATISTATIN Public/Granted day:2013-05-16
Information query
